During the past decade, Zhuanghe Central Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Zhuanghe Central Hospital" are "Acute Coronary Syndromes" (1 trials) and "Chemotherapy-induced Nausea and Vomiting" (1 trials). Many other conditions were trialed in "Zhuanghe Central Hospital" in a lesser frequency.

Most popular intervention types in "Zhuanghe Central Hospital" are "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-HT3 antagonists" (1 trials), "Dexamethasone" (1 trials), "Thalidomide" (1 trials) and "quality improvement initiatives" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zhuanghe Central Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Zhuanghe Central Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Zhuanghe Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zhuanghe Central Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".